Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Recs

0
Player Avatar syljtffreedom (85.20) Submitted: 2/23/2011 2:09:39 PM : Outperform Start Price: $50.43 AMGN Score: +35.60

good cash balances

Report this Post Reply

Featured Broker Partners


Advertisement